NEW YORK (GenomeWeb News) — Miraculins said yesterday it has pocketed CA$428,000 ($405,000) in a private stock placement by selling 1,222,858 units of certain shares at CA$.35 apiece.
 
The company said in July it could earn as much as CA$500,000 total from the sale by selling 1.25 million units at CA$.40 apiece.
 
Miraculins plans to use the money to fund research and development projects and to replenish working capital coffers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.